Proposals under this topic aim at integrating at EU level and providing access to a wide and inclusive portfolio of complementary research infrastructure services, including data services, and customised workflows supporting R&I projects along the development pipeline from discovery research to personalised treatment of cancer. Services should also support activities addressing the socio-economic dimension of cancer, the development of evidence-based public health measures and patient-centred approaches, as well as regulatory aspects of novel biomedical products or relevant biomarkers.

Expected Outcome: Project results are expected to contribute to all the following expected outcomes:

  • provision of innovative, customised and efficient RI services enhancing and increasing society’s long-term and consistent problem-solving capacity and evidence-based policy making in the health areas, including a better understanding of socio-economic implications;
  • advancement of knowledge for personalised cancer prevention strategies and treatments;
  • accelerated availability of solutions and products to patients in need;
  • wider access to specialised R&I services to underpin the competitiveness of the European industry and of biotech SMEs developing new personalised cancer prevention strategies and treatments.

Deadline date: 23 September 2021 17:00:00 Brussels time

All the information